Elissa S. Cote's most recent trade in VistaGen Therapeutics Inc was a trade of 75,000 Incentive Stock Option (right to buy) done . Disclosure was reported to the exchange on April 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| VistaGen Therapeutics Inc | Elissa S. Cote | Chief Corp Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2026 | 75,000 | 75,000 | - | - | Incentive Stock Option (right to buy) | |
| VistaGen Therapeutics Inc | Elissa S. Cote | Chief Corp Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2025 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) |